Baker Bros. Advisors »

Tyra Biosciences shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $147k 11k 13.85

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Mirati Therapeutics
Immunocore Holdings Ads (IMCR)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Invitae Corporation Notes 1.5% 4/1/2028 (Principal)
Abcellera Biologics (ABCL)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Entrada Therapeutics (TRDA)
Ultragenyx Pharmaceutical (RARE)

View all positions for Baker Bros. Advisors

Top funds holding Tyra Biosciences

RA Capital Management
Boxer Capital
Canaan Partners XI
BVF
Nextech Invest
Fairmount Funds Management
Frazier Life Sciences Management
Vanguard Group
5AM Venture Management
Jpmorgan Chase & Co
Perceptive Advisors
Kynam Capital Management
EcoR1 Capital
Charles Schwab Investment Management
Wellington Management Company

View all funds holding Tyra Biosciences